| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase binding | 1.36e-03 | 873 | 12 | 4 | GO:0019901 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.46e-03 | 891 | 12 | 4 | GO:0005198 | |
| GeneOntologyMolecularFunction | kinase binding | 1.99e-03 | 969 | 12 | 4 | GO:0019900 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.66e-03 | 130 | 12 | 2 | GO:0005200 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 9.92e-06 | 75 | 12 | 3 | GO:0045109 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 2.29e-05 | 99 | 12 | 3 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 2.36e-05 | 100 | 12 | 3 | GO:0045103 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.57e-04 | 189 | 12 | 3 | GO:0030216 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 5.18e-04 | 284 | 12 | 3 | GO:0009913 | |
| GeneOntologyBiologicalProcess | adherens junction organization | 5.57e-04 | 61 | 12 | 2 | GO:0034332 | |
| GeneOntologyBiologicalProcess | cellular pigmentation | 6.13e-04 | 64 | 12 | 2 | GO:0033059 | |
| GeneOntologyBiologicalProcess | epithelium development | 9.43e-04 | 1469 | 12 | 5 | GO:0060429 | |
| GeneOntologyBiologicalProcess | skin development | 1.14e-03 | 373 | 12 | 3 | GO:0043588 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 1.19e-03 | 870 | 12 | 4 | GO:0030855 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 1.69e-03 | 957 | 12 | 4 | GO:0097435 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 8.95e-05 | 899 | 12 | 5 | GO:0099513 | |
| GeneOntologyCellularComponent | intermediate filament | 2.59e-04 | 227 | 12 | 3 | GO:0005882 | |
| GeneOntologyCellularComponent | supramolecular fiber | 3.21e-04 | 1179 | 12 | 5 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 3.31e-04 | 1187 | 12 | 5 | GO:0099081 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 3.98e-04 | 263 | 12 | 3 | GO:0045111 | |
| GeneOntologyCellularComponent | nuclear body | 1.30e-03 | 903 | 12 | 4 | GO:0016604 | |
| GeneOntologyCellularComponent | nuclear speck | 1.67e-03 | 431 | 12 | 3 | GO:0016607 | |
| HumanPheno | Abnormal dermoepidermal hemidesmosome morphology | 2.54e-05 | 11 | 4 | 2 | HP:0032449 | |
| HumanPheno | Abnormal dermoepidermal junction morphology | 3.04e-05 | 12 | 4 | 2 | HP:0031538 | |
| HumanPheno | Abnormal skin morphology of the palm | 4.26e-05 | 413 | 4 | 4 | HP:0040211 | |
| HumanPheno | Palmoplantar hyperkeratosis | 6.23e-05 | 129 | 4 | 3 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 6.53e-05 | 131 | 4 | 3 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 6.68e-05 | 132 | 4 | 3 | HP:0007556 | |
| HumanPheno | Exertional dyspnea | 9.22e-05 | 147 | 4 | 3 | HP:0002875 | |
| HumanPheno | Pruritus | 9.60e-05 | 149 | 4 | 3 | HP:0000989 | |
| HumanPheno | Anti-neuromuscular Junction acetylcholine receptor antibody positivity | 1.06e-04 | 22 | 4 | 2 | HP:0030208 | |
| HumanPheno | Anti-acetylcholine receptor antibody positivity | 1.06e-04 | 22 | 4 | 2 | HP:6001064 | |
| HumanPheno | Abnormal palm morphology | 1.08e-04 | 521 | 4 | 4 | HP:0100871 | |
| HumanPheno | Nail dystrophy | 1.10e-04 | 156 | 4 | 3 | HP:0008404 | |
| HumanPheno | Regional abnormality of skin | 1.26e-04 | 541 | 4 | 4 | HP:0011356 | |
| HumanPheno | Abnormality of the plantar skin of foot | 1.45e-04 | 171 | 4 | 3 | HP:0100872 | |
| HumanPheno | Woolly hair | 1.74e-04 | 28 | 4 | 2 | HP:0002224 | |
| HumanPheno | Skin erosion | 1.74e-04 | 28 | 4 | 2 | HP:0200041 | |
| HumanPheno | Parakeratosis | 2.42e-04 | 33 | 4 | 2 | HP:0001036 | |
| HumanPheno | Fragile skin | 3.05e-04 | 37 | 4 | 2 | HP:0001030 | |
| HumanPheno | Absent facial hair | 3.22e-04 | 38 | 4 | 2 | HP:0002550 | |
| HumanPheno | Abnormal fingernail morphology | 3.51e-04 | 230 | 4 | 3 | HP:0001231 | |
| HumanPheno | Hyperkeratosis | 3.65e-04 | 233 | 4 | 3 | HP:0000962 | |
| HumanPheno | Aplasia cutis congenita | 3.75e-04 | 41 | 4 | 2 | HP:0001057 | |
| HumanPheno | Abnormality of keratinization | 4.19e-04 | 244 | 4 | 3 | HP:0001035 | |
| HumanPheno | Alopecia of scalp | 4.53e-04 | 45 | 4 | 2 | HP:0002293 | |
| HumanPheno | Scaling skin | 4.73e-04 | 46 | 4 | 2 | HP:0040189 | |
| HumanPheno | Alopecia | 5.12e-04 | 261 | 4 | 3 | HP:0001596 | |
| HumanPheno | Pterygium | 5.15e-04 | 48 | 4 | 2 | HP:0001059 | |
| HumanPheno | Nail dysplasia | 5.30e-04 | 264 | 4 | 3 | HP:0002164 | |
| HumanPheno | Pelvic girdle muscle weakness | 5.82e-04 | 51 | 4 | 2 | HP:0003749 | |
| HumanPheno | Abnormal morphology of the pelvis musculature | 6.05e-04 | 52 | 4 | 2 | HP:0001469 | |
| HumanPheno | Abnormality of the hip-girdle musculature | 6.05e-04 | 52 | 4 | 2 | HP:0001445 | |
| HumanPheno | Abnormal axial muscle morphology | 6.05e-04 | 52 | 4 | 2 | HP:0040286 | |
| HumanPheno | Epidermal acanthosis | 6.53e-04 | 54 | 4 | 2 | HP:0025092 | |
| HumanPheno | EMG abnormality | 7.22e-04 | 293 | 4 | 3 | HP:0003457 | |
| HumanPheno | Absent hair | 8.33e-04 | 61 | 4 | 2 | HP:0002298 | |
| HumanPheno | Anonychia | 9.76e-04 | 66 | 4 | 2 | HP:0001798 | |
| HumanPheno | Foot joint contracture | 1.06e-03 | 334 | 4 | 3 | HP:0008366 | |
| HumanPheno | Myopathy | 1.13e-03 | 341 | 4 | 3 | HP:0003198 | |
| HumanPheno | Childhood onset | 1.14e-03 | 938 | 4 | 4 | HP:0011463 | |
| HumanPheno | Sparse eyelashes | 1.29e-03 | 76 | 4 | 2 | HP:0000653 | |
| HumanPheno | Pulmonary fibrosis | 1.36e-03 | 78 | 4 | 2 | HP:0002206 | |
| HumanPheno | Gowers sign | 1.36e-03 | 78 | 4 | 2 | HP:0003391 | |
| HumanPheno | Aplastic/hypoplastic fingernail | 1.50e-03 | 82 | 4 | 2 | HP:0008384 | |
| HumanPheno | Epidermal thickening | 1.54e-03 | 379 | 4 | 3 | HP:0011368 | |
| HumanPheno | Lower-limb joint contracture | 1.85e-03 | 403 | 4 | 3 | HP:0005750 | |
| HumanPheno | Abnormal epidermal morphology | 1.97e-03 | 94 | 4 | 2 | HP:0011124 | |
| HumanPheno | Sparse or absent eyelashes | 2.02e-03 | 95 | 4 | 2 | HP:0200102 | |
| HumanPheno | Thickened skin | 2.26e-03 | 431 | 4 | 3 | HP:0001072 | |
| HumanPheno | Functional motor deficit | 2.33e-03 | 436 | 4 | 3 | HP:0004302 | |
| HumanPheno | Limb-girdle muscle weakness | 2.37e-03 | 103 | 4 | 2 | HP:0003325 | |
| HumanPheno | Orthopnea | 2.60e-03 | 108 | 4 | 2 | HP:0012764 | |
| HumanPheno | Limb joint contracture | 2.89e-03 | 469 | 4 | 3 | HP:0003121 | |
| HumanPheno | Palmoplantar keratoderma | 2.89e-03 | 114 | 4 | 2 | HP:0000982 | |
| HumanPheno | Abnormal blistering of the skin | 2.94e-03 | 115 | 4 | 2 | HP:0008066 | |
| HumanPheno | Neonatal death | 2.99e-03 | 116 | 4 | 2 | HP:0003811 | |
| HumanPheno | Cyanosis | 3.05e-03 | 117 | 4 | 2 | HP:0000961 | |
| HumanPheno | Fatigable weakness | 3.25e-03 | 121 | 4 | 2 | HP:0003473 | |
| HumanPheno | Abnormal synaptic transmission at the neuromuscular junction | 3.31e-03 | 122 | 4 | 2 | HP:0003398 | |
| HumanPheno | Abnormal peripheral nervous system synaptic transmission | 3.31e-03 | 122 | 4 | 2 | HP:0030191 | |
| HumanPheno | Abnormal synaptic transmission | 3.31e-03 | 122 | 4 | 2 | HP:0012535 | |
| HumanPheno | Abnormality of the amniotic fluid | 3.57e-03 | 504 | 4 | 3 | HP:0001560 | |
| HumanPheno | Dyspnea | 3.61e-03 | 506 | 4 | 3 | HP:0002094 | |
| HumanPheno | EMG: myopathic abnormalities | 3.69e-03 | 129 | 4 | 2 | HP:0003458 | |
| HumanPheno | Abnormal nail morphology | 3.82e-03 | 516 | 4 | 3 | HP:0001597 | |
| HumanPheno | Erythema | 3.92e-03 | 133 | 4 | 2 | HP:0010783 | |
| HumanPheno | Sparse or absent hair | 4.02e-03 | 525 | 4 | 3 | HP:0002115 | |
| HumanPheno | Arthrogryposis multiplex congenita | 4.46e-03 | 142 | 4 | 2 | HP:0002804 | |
| HumanPheno | Sparse eyebrow | 5.04e-03 | 151 | 4 | 2 | HP:0045075 | |
| HumanPheno | Abnormal pulmonary thoracic imaging finding | 5.44e-03 | 157 | 4 | 2 | HP:0031983 | |
| HumanPheno | Abnormal finger morphology | 5.45e-03 | 1385 | 4 | 4 | HP:0001167 | |
| MousePheno | dermal-epidermal separation | 2.02e-05 | 9 | 11 | 2 | MP:0011160 | |
| MousePheno | abnormal epidermal-dermal junction morphology | 3.70e-05 | 12 | 11 | 2 | MP:0011159 | |
| Domain | - | 5.67e-06 | 6 | 12 | 2 | 3.90.1290.10 | |
| Domain | Plectin_repeat | 7.93e-06 | 7 | 12 | 2 | IPR001101 | |
| Domain | Plectin | 7.93e-06 | 7 | 12 | 2 | PF00681 | |
| Domain | PLEC | 7.93e-06 | 7 | 12 | 2 | SM00250 | |
| Domain | Spectrin_repeat | 1.52e-04 | 29 | 12 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.86e-04 | 32 | 12 | 2 | IPR018159 | |
| Domain | SPEC | 1.86e-04 | 32 | 12 | 2 | SM00150 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 2.39e-04 | 37 | 9 | 2 | MM14488 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 2.52e-04 | 38 | 9 | 2 | M495 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 4.20e-04 | 49 | 9 | 2 | MM15448 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 4.73e-04 | 52 | 9 | 2 | M2341 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 7.61e-04 | 66 | 9 | 2 | MM15925 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.32e-03 | 87 | 9 | 2 | MM15351 | |
| Pathway | REACTOME_APOPTOSIS | 2.02e-03 | 108 | 9 | 2 | MM14471 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.87e-03 | 129 | 9 | 2 | M27649 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 3.46e-03 | 142 | 9 | 2 | MM15178 | |
| Pathway | REACTOME_KERATINIZATION | 4.01e-03 | 153 | 9 | 2 | MM15343 | |
| Pathway | REACTOME_APOPTOSIS | 5.44e-03 | 179 | 9 | 2 | M15303 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 7.49e-03 | 211 | 9 | 2 | M27436 | |
| Pathway | REACTOME_KERATINIZATION | 7.91e-03 | 217 | 9 | 2 | M27640 | |
| Pubmed | 9.30e-08 | 131 | 12 | 4 | 28634551 | ||
| Pubmed | 1.00e-06 | 591 | 12 | 5 | 15231748 | ||
| Pubmed | 1.66e-06 | 655 | 12 | 5 | 35819319 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.02e-06 | 283 | 12 | 4 | 30585729 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.75e-06 | 774 | 12 | 5 | 15302935 | |
| Pubmed | 3.92e-06 | 9 | 12 | 2 | 15500642 | ||
| Pubmed | 3.92e-06 | 9 | 12 | 2 | 12482924 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.22e-06 | 341 | 12 | 4 | 32971831 | |
| Pubmed | 5.99e-06 | 11 | 12 | 2 | 12802069 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.04e-05 | 954 | 12 | 5 | 36373674 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.05e-05 | 430 | 12 | 4 | 35044719 | |
| Pubmed | 1.39e-05 | 1014 | 12 | 5 | 32416067 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.62e-05 | 148 | 12 | 3 | 32538781 | |
| Pubmed | 1.73e-05 | 488 | 12 | 4 | 31324722 | ||
| Pubmed | 1.85e-05 | 496 | 12 | 4 | 31343991 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.91e-05 | 1082 | 12 | 5 | 38697112 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 3.05e-05 | 564 | 12 | 4 | 21565611 | |
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 3.26e-05 | 25 | 12 | 2 | 30309841 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.45e-05 | 582 | 12 | 4 | 20467437 | |
| Pubmed | 3.53e-05 | 26 | 12 | 2 | 20301347 | ||
| Pubmed | 5.05e-05 | 31 | 12 | 2 | 22323290 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 5.20e-05 | 219 | 12 | 3 | 31353912 | |
| Pubmed | 5.41e-05 | 653 | 12 | 4 | 22586326 | ||
| Pubmed | 6.33e-05 | 234 | 12 | 3 | 36243803 | ||
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 7.07e-05 | 243 | 12 | 3 | 36964488 | |
| Pubmed | 8.38e-05 | 731 | 12 | 4 | 29298432 | ||
| Pubmed | 1.02e-04 | 44 | 12 | 2 | 27505670 | ||
| Pubmed | 1.04e-04 | 277 | 12 | 3 | 30745168 | ||
| Pubmed | 1.24e-04 | 809 | 12 | 4 | 32129710 | ||
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 1.35e-04 | 302 | 12 | 3 | 30561431 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.50e-04 | 313 | 12 | 3 | 38270169 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.58e-04 | 861 | 12 | 4 | 36931259 | |
| Pubmed | 1.60e-04 | 55 | 12 | 2 | 33067418 | ||
| Pubmed | 1.66e-04 | 56 | 12 | 2 | 37059927 | ||
| Pubmed | 2.11e-04 | 63 | 12 | 2 | 37052853 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.15e-04 | 934 | 12 | 4 | 33916271 | |
| Pubmed | 2.75e-04 | 72 | 12 | 2 | 36123327 | ||
| Interaction | KIF20A interactions | 6.51e-07 | 1052 | 12 | 7 | int:KIF20A | |
| Interaction | CLK4 interactions | 2.11e-06 | 44 | 12 | 3 | int:CLK4 | |
| Interaction | CDC5L interactions | 4.25e-06 | 855 | 12 | 6 | int:CDC5L | |
| Interaction | RNF113A interactions | 3.05e-05 | 692 | 12 | 5 | int:RNF113A | |
| Interaction | SNW1 interactions | 4.40e-05 | 747 | 12 | 5 | int:SNW1 | |
| Interaction | MECP2 interactions | 4.43e-05 | 1287 | 12 | 6 | int:MECP2 | |
| Interaction | EED interactions | 8.52e-05 | 1445 | 12 | 6 | int:EED | |
| Interaction | SLTM interactions | 9.51e-05 | 156 | 12 | 3 | int:SLTM | |
| Interaction | HNRNPA1 interactions | 1.35e-04 | 945 | 12 | 5 | int:HNRNPA1 | |
| Interaction | PRC1 interactions | 1.55e-04 | 973 | 12 | 5 | int:PRC1 | |
| Interaction | SMC5 interactions | 1.76e-04 | 1000 | 12 | 5 | int:SMC5 | |
| Interaction | COL17A1 interactions | 1.80e-04 | 34 | 12 | 2 | int:COL17A1 | |
| Interaction | CLK2 interactions | 1.84e-04 | 195 | 12 | 3 | int:CLK2 | |
| Interaction | KRT16 interactions | 1.90e-04 | 197 | 12 | 3 | int:KRT16 | |
| Interaction | CPSF6 interactions | 1.92e-04 | 526 | 12 | 4 | int:CPSF6 | |
| Interaction | CLK3 interactions | 2.63e-04 | 220 | 12 | 3 | int:CLK3 | |
| Interaction | ARRDC3 interactions | 2.77e-04 | 224 | 12 | 3 | int:ARRDC3 | |
| Interaction | CDK1 interactions | 2.98e-04 | 590 | 12 | 4 | int:CDK1 | |
| Interaction | DDX24 interactions | 3.10e-04 | 596 | 12 | 4 | int:DDX24 | |
| Interaction | NPHP4 interactions | 3.23e-04 | 236 | 12 | 3 | int:NPHP4 | |
| Interaction | PPP1R9B interactions | 3.74e-04 | 626 | 12 | 4 | int:PPP1R9B | |
| Interaction | DHX40 interactions | 3.78e-04 | 249 | 12 | 3 | int:DHX40 | |
| Interaction | TRIM37 interactions | 3.83e-04 | 630 | 12 | 4 | int:TRIM37 | |
| Interaction | CPSF1 interactions | 4.05e-04 | 255 | 12 | 3 | int:CPSF1 | |
| Interaction | KPLCE interactions | 4.57e-04 | 54 | 12 | 2 | int:KPLCE | |
| Interaction | PCBP1 interactions | 4.87e-04 | 671 | 12 | 4 | int:PCBP1 | |
| Interaction | KRT19 interactions | 5.43e-04 | 282 | 12 | 3 | int:KRT19 | |
| Interaction | KRT39 interactions | 5.46e-04 | 59 | 12 | 2 | int:KRT39 | |
| Interaction | SFN interactions | 5.47e-04 | 692 | 12 | 4 | int:SFN | |
| Interaction | ACTC1 interactions | 5.53e-04 | 694 | 12 | 4 | int:ACTC1 | |
| Interaction | KPRP interactions | 5.54e-04 | 284 | 12 | 3 | int:KPRP | |
| Interaction | TOP1 interactions | 5.59e-04 | 696 | 12 | 4 | int:TOP1 | |
| Interaction | FES interactions | 5.83e-04 | 61 | 12 | 2 | int:FES | |
| Interaction | MZT1 interactions | 5.83e-04 | 61 | 12 | 2 | int:MZT1 | |
| Interaction | DHX8 interactions | 6.01e-04 | 292 | 12 | 3 | int:DHX8 | |
| Interaction | SIRT7 interactions | 7.19e-04 | 744 | 12 | 4 | int:SIRT7 | |
| Interaction | CDKL2 interactions | 7.89e-04 | 71 | 12 | 2 | int:CDKL2 | |
| Interaction | PRPF8 interactions | 8.43e-04 | 776 | 12 | 4 | int:PRPF8 | |
| Interaction | TRA2A interactions | 8.58e-04 | 330 | 12 | 3 | int:TRA2A | |
| Interaction | RSRC2 interactions | 8.80e-04 | 75 | 12 | 2 | int:RSRC2 | |
| Interaction | SHROOM3 interactions | 9.52e-04 | 78 | 12 | 2 | int:SHROOM3 | |
| Interaction | FOXO1 interactions | 9.92e-04 | 347 | 12 | 3 | int:FOXO1 | |
| Interaction | PIAS1 interactions | 1.04e-03 | 353 | 12 | 3 | int:PIAS1 | |
| Interaction | NUDT21 interactions | 1.18e-03 | 369 | 12 | 3 | int:NUDT21 | |
| Interaction | IQCB1 interactions | 1.19e-03 | 370 | 12 | 3 | int:IQCB1 | |
| Interaction | WDR76 interactions | 1.32e-03 | 383 | 12 | 3 | int:WDR76 | |
| Interaction | C6orf141 interactions | 1.32e-03 | 92 | 12 | 2 | int:C6orf141 | |
| Interaction | ZC3H18 interactions | 1.33e-03 | 877 | 12 | 4 | int:ZC3H18 | |
| Interaction | CPSF4 interactions | 1.38e-03 | 94 | 12 | 2 | int:CPSF4 | |
| Interaction | KHDRBS3 interactions | 1.38e-03 | 94 | 12 | 2 | int:KHDRBS3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 5.26e-03 | 423 | 12 | 2 | chr12q13 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.79e-06 | 8 | 8 | 2 | 939 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 195 | 12 | 3 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 195 | 12 | 3 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.82e-05 | 199 | 12 | 3 | c1daa481f88d5281b6b5ea8ec8bb70cc0907d613 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.82e-05 | 199 | 12 | 3 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Mild/Remission-B_naive-13|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.39e-04 | 142 | 12 | 2 | 49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.57e-04 | 144 | 12 | 2 | 3ba7f8bd6d1c551048403c94693d63e60f7cbbb7 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.57e-04 | 144 | 12 | 2 | 38ff324366ad5be626e3657c1e33277fc36ddd4c | |
| ToppCell | Healthy-B_cell|World / disease group, cell group and cell class | 6.76e-04 | 146 | 12 | 2 | 588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f | |
| ToppCell | Healthy-B_cell|Healthy / disease group, cell group and cell class | 7.42e-04 | 153 | 12 | 2 | 7f82cd61b3f1ebaee3e4bbf68ba858a67c2065e7 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-04 | 158 | 12 | 2 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.00e-04 | 159 | 12 | 2 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-13|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.31e-04 | 162 | 12 | 2 | 28b3a6ae5519a267eefb70436d3190a387d027b9 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.41e-04 | 163 | 12 | 2 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-04 | 164 | 12 | 2 | ea02ca343b2b28e437304de889e2ae1e315a1197 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.82e-04 | 167 | 12 | 2 | 29d271643f3a1718b53db77b7d093ec94225a824 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.03e-04 | 169 | 12 | 2 | 3e267ec9f884df326315500dfd751b04a3dd91bd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.03e-04 | 169 | 12 | 2 | 1dfaf9a6b433a5ee86a11962af188978c2543278 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 9.03e-04 | 169 | 12 | 2 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.14e-04 | 170 | 12 | 2 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.14e-04 | 170 | 12 | 2 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.14e-04 | 170 | 12 | 2 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.24e-04 | 171 | 12 | 2 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.24e-04 | 171 | 12 | 2 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.24e-04 | 171 | 12 | 2 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.24e-04 | 171 | 12 | 2 | 3a2fefcb62e9d47ae6b3a946c45d3f2dd32c576c | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.24e-04 | 171 | 12 | 2 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-04 | 171 | 12 | 2 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.24e-04 | 171 | 12 | 2 | 3ef44a5e3e8f81424f1e9aa302860b6688a549b8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-4_RORB_FOLH1B|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.35e-04 | 172 | 12 | 2 | bbbd013ce554b2f93e463438fed20ec03fe87780 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.90e-04 | 177 | 12 | 2 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.90e-04 | 177 | 12 | 2 | c80893e5cf5688ee9f5afc8f11b3890f296c9e1f | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 178 | 12 | 2 | a3176b2b335db22bb0fb71aafa5d7a287809396e | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-03 | 178 | 12 | 2 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-03 | 178 | 12 | 2 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-4_RORB_FOLH1B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-03 | 178 | 12 | 2 | 22955b82917206aeed49dc0ac4630ccd9e51c4a5 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-03 | 179 | 12 | 2 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-03 | 179 | 12 | 2 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-03 | 179 | 12 | 2 | e7045e27f0eb88f552b31c04b56d78e5ccd7a36c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-03 | 179 | 12 | 2 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-03 | 179 | 12 | 2 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-03 | 180 | 12 | 2 | d553aba594f5304f1c09ff9c6d49b64cd7ee7850 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-03 | 180 | 12 | 2 | 25f8e82bbc1853cb7d072484e99369c72779dd1e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-03 | 181 | 12 | 2 | cb17c904ab86d56dd30cac9b61acbb3b76f84ded | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-03 | 181 | 12 | 2 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-03 | 182 | 12 | 2 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 182 | 12 | 2 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-03 | 182 | 12 | 2 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-03 | 182 | 12 | 2 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 182 | 12 | 2 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-03 | 182 | 12 | 2 | d1a1feef318062f25493355d7beee8e5fb0e4206 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-03 | 183 | 12 | 2 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.06e-03 | 183 | 12 | 2 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-03 | 183 | 12 | 2 | 06ac66726ec53db810ebb90ec69cfdb903da53f6 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.06e-03 | 183 | 12 | 2 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-03 | 183 | 12 | 2 | bbf27d2f4369031fadacacd6c432c06b1ec5abdb | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-03 | 183 | 12 | 2 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-03 | 184 | 12 | 2 | 886d2d9bf2fe31207f17e3edc309ef44029924e1 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-03 | 184 | 12 | 2 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-03 | 184 | 12 | 2 | 936b39377eebea3961d702532779f6cd27953be7 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-03 | 184 | 12 | 2 | 4cb5f299dd7413e0be1ad7af817ee614b23a18ae | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-03 | 184 | 12 | 2 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-03 | 184 | 12 | 2 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-03 | 184 | 12 | 2 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-03 | 184 | 12 | 2 | 39bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-03 | 184 | 12 | 2 | e123ad8ee46a032825a0bd4b3586ddcb3eda03d4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 185 | 12 | 2 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 185 | 12 | 2 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-03 | 185 | 12 | 2 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 185 | 12 | 2 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-03 | 185 | 12 | 2 | 2088e82e0febdcf05618d3db913d00e2e87812f4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-03 | 185 | 12 | 2 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 185 | 12 | 2 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-03 | 185 | 12 | 2 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 185 | 12 | 2 | 502361b041a036de024eb5fe378ca09fac9b67ee | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 185 | 12 | 2 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-03 | 185 | 12 | 2 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 185 | 12 | 2 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 185 | 12 | 2 | 68f428e169cfb77de970bdfdeea9b9f16f68d2ba | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.08e-03 | 185 | 12 | 2 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-03 | 186 | 12 | 2 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-03 | 186 | 12 | 2 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-03 | 186 | 12 | 2 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 186 | 12 | 2 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 186 | 12 | 2 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.09e-03 | 186 | 12 | 2 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-03 | 186 | 12 | 2 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-03 | 187 | 12 | 2 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-03 | 187 | 12 | 2 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.10e-03 | 187 | 12 | 2 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 1.10e-03 | 187 | 12 | 2 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-03 | 187 | 12 | 2 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 188 | 12 | 2 | c300accbac71a3bc075fe985543d8a8ead82531b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-03 | 188 | 12 | 2 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.12e-03 | 188 | 12 | 2 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-03 | 188 | 12 | 2 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.12e-03 | 188 | 12 | 2 | e7681efb4d2de7f1d8a89552fff76a829376bf1b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-03 | 188 | 12 | 2 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 188 | 12 | 2 | 14e120b20e76baa07b6510a94f0c2dcdfdd52357 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 1.13e-03 | 189 | 12 | 2 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-03 | 189 | 12 | 2 | f44ddb6cdbb406b0528a9b0ba3811183ab6d1fc6 | |
| Computational | Intermediate filaments and MT. | 8.11e-04 | 68 | 7 | 2 | MODULE_438 | |
| Disease | hemifacial microsomia | 2.58e-05 | 19 | 12 | 2 | MONDO_0015398 | |
| Disease | Myasthenic Syndromes, Congenital | 4.16e-05 | 24 | 12 | 2 | C0751882 | |
| Disease | Muscular Dystrophies, Limb-Girdle | 7.47e-05 | 32 | 12 | 2 | C0686353 | |
| Disease | triacylglycerol 56:6 measurement | 1.36e-04 | 43 | 12 | 2 | EFO_0010433 | |
| Disease | polyp of colon | 2.31e-04 | 56 | 12 | 2 | MONDO_0021400 | |
| Disease | cortical thickness | 7.82e-04 | 1113 | 12 | 4 | EFO_0004840 | |
| Disease | fibrinogen measurement | 8.71e-04 | 109 | 12 | 2 | EFO_0004623 | |
| Disease | FEV/FEC ratio | 1.13e-03 | 1228 | 12 | 4 | EFO_0004713 | |
| Disease | serum albumin measurement | 1.54e-03 | 592 | 12 | 3 | EFO_0004535 | |
| Disease | resting heart rate | 1.62e-03 | 149 | 12 | 2 | EFO_0004351 | |
| Disease | hair colour measurement | 1.72e-03 | 615 | 12 | 3 | EFO_0007822 | |
| Disease | calcium measurement | 1.83e-03 | 628 | 12 | 3 | EFO_0004838 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKTYSLSSSFSSSSS | 556 | O60563 | |
| SGSSYSRSSYTYSKS | 691 | Q7Z6E9 | |
| HYSDSTVTSTSSRDY | 671 | Q14112 | |
| SSYSYSYSFSSSSIG | 2856 | P15924 | |
| ATGSHSSYSSSLSSY | 341 | Q18PE1 | |
| SSYSSSLSSYAGSSL | 346 | Q18PE1 | |
| TTSSITSGYFSHSAS | 1591 | Q9H1H9 | |
| QSYHSSSSTSDLSNY | 191 | Q8TF72 | |
| SVSSYSSYSLSSSFP | 6 | Q8N365 | |
| SSSSPSLSGTSYSFS | 646 | G9CGD6 | |
| SMTFSSSSYSSSGYG | 4651 | Q15149 | |
| SYSSSSSSSQSYLSH | 206 | P49750 | |
| SSSSQSYLSHSQSYL | 211 | P49750 | |
| SSSYSSYSSRSSRHS | 576 | Q86VM9 | |
| ISSSSYSYHHPSSAG | 466 | Q7RTS7 |